法国美容医学市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

法国美容医学市场已按产品(肉毒杆菌毒素、皮肤填充剂、化学换肤和微晶换肤术)和最终用户(美容诊所、医院和其他最终用户)进行细分。

市场快照

France Aesthetic Medicine Market Overview
Study Period: 2018 - 2026
Base Year: 2021
CAGR: 8.58 %
France Aesthetic Medicine Market Major players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

推动市场增长的关键因素是越来越多地采用非侵入性美容程序、提高客户的意识以及用户友好型美容产品的可用性。

在法国,据观察,患者在很小的时候就开始使用抗衰老技术和微创治疗,并且需要更多的侵入性手术来保持年轻的容貌。此外,可支配收入的增加刺激了对整容手术的需求,从而加速了市场增长。

随着人们对美容程序潜在益处的认识不断提高,人们也倾向于在美容治疗中使用最小或非侵入性程序。无创或微创技术在法国越来越受欢迎。显着倾向的原因是大多数观众认为正常的手术治疗是痛苦的并且具有高风险因素。因此,越来越多地采用无创或微创美容程序正在推动法国美容医学市场的增长。

此外,广告大量兴起,展示各种美容程序的“之前”和“之后”差异,从而促使青年和中年人接受医学美容程序。

报告范围

根据报告的范围,美容医学被定义为专注于通过治疗衰老、感染或疾病皮肤状况来改善美容外观的专业。美容医学和整容手术正在发展临床亚专业和科学研究领域,其中包括旨在改善患者外貌的各种医疗程序,包括所有无创和微创美容程序。

By Product
Botulinum Toxin
Dermal Filler
Absorbable Dermal Filler
Non-absorbable Dermal Filler
Chemical Peel
Microdermabrasion
By End User
Aesthetic Clinics
Hospitals
Other End Users

Report scope can be customized per your requirements. Click here.

主要市场趋势

真皮填充剂预计将在预测期内增长最大

  • 真皮填充剂市场份额最大,预计在预测期内将继续。它在法国不断发展,每年销售量约为 850,000 支皮肤注射器。
  • 由于副作用最小,可吸收皮肤填充剂对法国整个皮肤填充剂市场的贡献最大。另一方面,法国的机构目前不建议将不可吸收的产品用于美容目的,因为存在极延迟、无法控制和严重不良反应的风险。
France Aesthetic Medicine Market trends

France Aesthetic Medicine Market growth

竞争格局

法国美容医学市场相当巩固,一些本地参与者与国际参与者竞争。大多数主要行业参与者采用的主要策略包括新产品发布、收购、合并和合作伙伴关系,以加强美学产品组合并保持其市场定位。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Adoption of Non- and Minimally-Invasive Aesthetic Procedures

      2. 4.2.2 Increasing Awareness among Customers about Cosmetic Procedures

      3. 4.2.3 Availability of Technologically Advanced & User-friendly Products

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Safety Regulations for Aesthetic Procedures

      2. 4.3.2 Risk of Side Effects

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Botulinum Toxin

      2. 5.1.2 Dermal Filler

        1. 5.1.2.1 Absorbable Dermal Filler

        2. 5.1.2.2 Non-absorbable Dermal Filler

      3. 5.1.3 Chemical Peel

      4. 5.1.4 Microdermabrasion

    2. 5.2 By End User

      1. 5.2.1 Aesthetic Clinics

      2. 5.2.2 Hospitals

      3. 5.2.3 Other End Users

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 AbbVie Inc. (AlLergan Plc)

      2. 6.1.2 Bioxis Pharmaceuticals

      3. 6.1.3 Dermaceutic Laboratoire

      4. 6.1.4 Ipsen Pharma

      5. 6.1.5 Sinclair Pharma PLC

      6. 6.1.6 Johnson & Johnson

      7. 6.1.7 Galderma(Nestle Skin Health)

      8. 6.1.8 Merz Pharma GmbH & Co. KGaA

      9. 6.1.9 Laboratoires Filorga

      10. 6.1.10 Teoxane Laboratories

      11. 6.1.11 Laboratories Vivacy

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The France Aesthetic Medicine Market market is studied from 2018 - 2026.

The France Aesthetic Medicine Market is growing at a CAGR of 8.58% over the next 5 years.

AbbVie Inc. (AlLergan Plc), Bioxis Pharmaceuticals, Dermaceutic Laboratoire, Ipsen Pharma, Johnson & Johnson are the major companies operating in France Aesthetic Medicine Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!